TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CABA

Cabaletta Bio Inc

Healthcare · Biotechnology

2.60$ -1.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Cabaletta Bio Inc (CABA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 257 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CABA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
173 254 240 217 204 185 165 225 190 165 148 257
166 244 227 206 186 167 135 198 165 139 122 231
116 193 175 179 171 164 132 146 60 83 117 225
164 241 224 203 183 164 132 195 160 134 117 225
12 17 19 18 30 33 44 46 50 53 45 46
11 16 18 18 23 27 34 42 46 50 42 40
2.5 3.6 7.4 7.4 7.9 10.0 19 20 21 24 23 19
3.6 4.5 5.8 4.2 2.2 4.9 6.5 7.2 8.3 6.6 6.4 5.8
161 236 222 200 174 152 122 178 139 112 103 211
-212 -233 -258 -286 -317 -349 -385 -430 -475 -517 -560 -611
44 44 49 49 49 50 49 62 102 102 112 151

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?